Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunoglobulins--basic considerations.

Eilhard Mix1, Robert Goertsches, Uwe K Zett

  • 1University of Rostock, Dept. of Neurology, Gehlsheimer Str. 20, 18147, Rostock, Germany. eilhard.mix@med.uni-rostock.de

Journal of Neurology
|September 26, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Frequency and risk factors of antibody-induced secondary failure of botulinum neurotoxin therapy.

Neurology·2020
Same author

Intrastriatal injection of botulinum neurotoxin-A is not cytotoxic in rat brain - A histological and stereological analysis.

Brain research·2015
Same author

Secondary antibody-induced treatment failure under therapy with incobotulinumtoxinA (Xeomin®) in a patient with segmental dystonia pretreated with abobotulinumtoxinA (Dysport®).

Journal of the neurological sciences·2015
Same author

Behavioral and structural effects of unilateral intrastriatal injections of botulinum neurotoxin a in the rat model of Parkinson's disease.

Journal of neuroscience research·2013
Same author

Intracerebrally applied botulinum neurotoxin in experimental neuroscience.

Current pharmaceutical biotechnology·2012
Same author

Elevation in type I interferons inhibits HCN1 and slows cortical neuronal oscillations.

Cerebral cortex (New York, N.Y. : 1991)·2012
Same journal

The dual role of mTOR in multiple sclerosis pathophysiology: a systematic review.

Journal of neurology·2026
Same journal

Brain-first versus body-first Parkinson's disease: Differential findings on pupillary, brainstem and vagus sonography.

Journal of neurology·2026
Same journal

Spontaneous intracranial hypotension due to pelvic cerebrospinal fluid leak.

Journal of neurology·2026
Same journal

Morbidity and medication use preceding a diagnosis of late-onset Alzheimer's disease: a Danish nationwide study.

Journal of neurology·2026
Same journal

Comorbid autoimmune disease in stiff-person syndrome spectrum disorder: a systematic review and meta-analysis.

Journal of neurology·2026
Same journal

Tetrahydrocannabinol/cannabidiol in the treatment of restless legs syndrome.

Journal of neurology·2026
See all related articles

Antibodies (immunoglobulins) are key to adaptive immunity, with diverse structures generated for various functions. Their dysregulation can lead to disease, but they also offer diagnostic and therapeutic applications in medicine.

Area of Science:

  • Immunology
  • Molecular Biology
  • Medical Diagnostics and Therapeutics

Background:

  • Antibodies (immunoglobulins) are central to the adaptive humoral immune response.
  • Their functional diversity is achieved through complex genetic mechanisms and cellular processes.
  • B cell subsets (B1 and B2) contribute differently to innate and adaptive immunity.

Purpose of the Study:

  • To elucidate the structural optimization and diversity generation of antibodies.
  • To explore the roles of B cell subsets and key enzymes in antibody diversification.
  • To highlight the diagnostic and therapeutic applications of antibodies in medicine.

Main Methods:

  • Analysis of V-D-J recombination, junctional diversity, and light/heavy chain association.

Related Experiment Videos

  • Investigation of isotype class switching and somatic hypermutation.
  • Review of diagnostic techniques (serology, immunocytochemistry, immunoassays) and therapeutic strategies (passive immunization, monoclonal antibodies).

    • Main Results:

    • Antibodies exhibit optimized structures for diverse functions including antigen recognition, immune cell activation, and transport.
    • Enzymes like RAG1/RAG2 and AID are crucial for generating antibody diversity.
    • Impaired B cell immunity leads to immunodeficiency, malignancy, or immune dysregulation.

    Conclusions:

    • Antibody structure and diversity are essential for effective adaptive immunity.
    • Diagnostic and therapeutic applications of antibodies, especially monoclonal antibodies, have significantly advanced modern medicine.
    • Understanding B cell biology is critical for managing immune-related diseases.